APA (7th ed.) Citation

Wu, N., Li, X., Zeng, C., Shang, J., Yang, X., & Xue, Q. Pretreatment with oral contraceptives benefit POSEIDON group 1 low prognosis patients during GnRH-antagonist protocol: A propensity score-matched retrospective cohort study. BMC.

Chicago Style (17th ed.) Citation

Wu, Ning, Xin Li, Cheng Zeng, Jing Shang, Xiuli Yang, and Qing Xue. Pretreatment with Oral Contraceptives Benefit POSEIDON Group 1 Low Prognosis Patients During GnRH-antagonist Protocol: A Propensity Score-matched Retrospective Cohort Study. BMC.

MLA (9th ed.) Citation

Wu, Ning, et al. Pretreatment with Oral Contraceptives Benefit POSEIDON Group 1 Low Prognosis Patients During GnRH-antagonist Protocol: A Propensity Score-matched Retrospective Cohort Study. BMC.